D-0310-2021 Class I Terminated

Recalled by Adams.Secret.Co — Fairview, NJ

FDA drug recall D-0310-2021 was initiated by Adams.Secret.Co on Feb 15, 2021 and is designated Class I. Reason for recall: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil. The recall status is terminated (terminated Apr 20, 2022). Affected quantity: 218 boxes.

Recall details

Product Type
Drugs
Report Date
Mar 31, 2021
Initiation Date
Feb 15, 2021
Termination Date
Apr 20, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
218 boxes

Product description

Adam's Secret Extra Strength 1500, 800 mg, 10 count blister packs, Distributed by KP Inc., Made in USA, UPC 6 09728 43462 5

Reason for recall

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

Distribution pattern

Nationwide in the USA

Code information

All lots within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0310-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0310-2021. Report a data issue: hello@regdatalab.com.